[The TGF-β signaling pathway induced EMT in breast cancer]

Insights

Epithelial-mesenchymal transition (EMT) drives breast cancer metastasis and drug resistance. This review details how the transforming growth factor beta (TGF-β) signaling pathway regulates EMT in breast cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Epithelial-mesenchymal transition (EMT) is a cellular process crucial for embryonic development and wound healing.
  • EMT involves the loss of epithelial characteristics and acquisition of mesenchymal traits, enabling cell migration.
  • In breast cancer, EMT is linked to tumor progression, metastasis, and resistance to therapies.

Purpose of the Study:

  • To review the role of the transforming growth factor beta (TGF-β) signaling pathway in inducing EMT.
  • To explore the mechanisms by which TGF-β signaling drives EMT in breast cancer.
  • To provide an overview of current understanding regarding TGF-β-induced EMT in breast cancer.

Main Methods:

  • Literature review of scientific articles and research papers.
  • Analysis of studies focusing on TGF-β signaling pathways and EMT.
  • Synthesis of information on molecular players and regulatory networks involved.

Main Results:

  • TGF-β signaling is a critical regulator of EMT in breast cancer.
  • Activation of TGF-β pathway leads to molecular changes characteristic of EMT.
  • EMT contributes significantly to the metastatic potential and therapeutic challenges in breast cancer.

Conclusions:

  • The TGF-β signaling pathway is a key driver of EMT in breast cancer.
  • Understanding TGF-β-induced EMT is vital for developing targeted anti-metastatic therapies.
  • Further research into TGF-β signaling mechanisms can offer new therapeutic strategies for breast cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.5K